Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study

PLoS ONE- United States

doi 10.1371/journal.pone.0122073

Full Text

Abstract

Available in

Date

Authors

Publisher

Public Library of Science (PLoS)

Related search

Early Changes in Monocyte Adhesion Molecule Expression and Tumor Necrosis Factor-Α Levels in Chronic Kidney Disease - A 5-Year Prospective Study

American Journal of Nephrology
Nephrology
2016English

Soluble Interleukin-2 Receptor and Tumor Necrosis Factor Levels in Depressed Patients in Estonia

Medicina
Medicine
2009English

Snoring and Incident Chronic Kidney Disease: A Community-Based Prospective Cohort Study

BMJ Open
Medicine
2019English

CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

Tumor Necrosis Factor (TNF) Receptor 1 Signaling Downstream of TNF Receptor-Associated Factor 2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Soluble Tumor Necrosis Factor Receptor Type I Enhances Tumor Development and Persistence in Vivo

Cellular Immunology
Immunology
2000English

The Tumor Necrosis Factor Receptor 2 Signal Transducers TRAF2 and C-Iap1 Are Components of the Tumor Necrosis Factor Receptor 1 Signaling Complex

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Proteinuria as a Therapeutic Target in Advanced Chronic Kidney Disease: A Retrospective Multicenter Cohort Study

Scientific Reports
Multidisciplinary
2016English

Tumor Necrosis Factor Receptor 1 Associated Periodic Syndrome

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy